These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13952193)

  • 21. Alpha methyl dopa in the treatment of hypertension.
    DOYLE A; TREVAKS G
    Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654
    [No Abstract]   [Full Text] [Related]  

  • 22. ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.
    SMITH CB
    J Pharmacol Exp Ther; 1963 Dec; 142():343-50. PubMed ID: 14098331
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of alpha-methyl-dopa for the treatment of chronic hypertension].
    ARNOLD OH
    Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447
    [No Abstract]   [Full Text] [Related]  

  • 24. [EFFECT OF ALPHA-METHYLDOPALANINE AND SERYLTRIHYDROXYBENZYLHYDRAZINE (RO 4-4602) ON THE DOPA-DECARBOXYLASE ACTIVITY].
    CHRUSCIEL TL; POJDA SM
    Acta Physiol Pol; 1965; 16():111-5. PubMed ID: 14338596
    [No Abstract]   [Full Text] [Related]  

  • 25. MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA.
    MORAN JF; SOURKES TL
    J Pharmacol Exp Ther; 1965 May; 148():252-61. PubMed ID: 14301016
    [No Abstract]   [Full Text] [Related]  

  • 26. Febrile reactions to L-alpha-methyl-dopa. Report of three cases.
    LEONARD JW; GIFFORD RW; HUMPHREY DC
    Cleve Clin Q; 1962 Jul; 29():144-7. PubMed ID: 14464072
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
    GILLESPIE L; OATES JA; CROUT JR; SJOERDSMA A
    Circulation; 1962 Feb; 25():281-91. PubMed ID: 13898638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition of serotonin formation by alpha-methyl-DOPA].
    WESTERMANN E; BALZER H; KNELL J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):194-205. PubMed ID: 13600388
    [No Abstract]   [Full Text] [Related]  

  • 29. [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].
    SCHAUB F; NAGER F; SCHAER H; ZIEGLER W; LICHTLEN P
    Schweiz Med Wochenschr; 1962 May; 92():620-8. PubMed ID: 14498080
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary report on the clinical effectiveness of 1-alpha-methyl-DOPA (Aldomet) in the treatment of hypertension].
    FELLINGER K; GRABNER G; KRYGICZ H
    Wien Z Inn Med; 1961 Dec; 42():527-30. PubMed ID: 13892223
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of the combination of L-alpha-methyldopa and dichlorothiazide in the treatment of arterial hypertension].
    BAILA MR; CINTAS JA
    Dia Med; 1962 Dec; 34():2422-4. PubMed ID: 13969004
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of alpha-methyl DOPA in severe and malignant hypertension.
    CANNON PJ; WHITLOCK RT; MORRIS RC; ANGERS M; LARAGH JH
    JAMA; 1962 Mar; 179():673-81. PubMed ID: 13876240
    [No Abstract]   [Full Text] [Related]  

  • 33. ANALOGS OF METHYLDOPA AND DOPA. HYDANTOIC ACIDS AND HYDANTOINS.
    VITALI RA; JACOB TA; CHEMERDA JM
    J Med Chem; 1964 May; 7():379-81. PubMed ID: 14204992
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of DOPA and alpha-methyl-DOPA on the development of neurogenic dystrophy of the gastric wall and catecholamine content of the stomach].
    Zabrodin ON
    Biull Eksp Biol Med; 1970 Jul; 70(7):58-60. PubMed ID: 5501776
    [No Abstract]   [Full Text] [Related]  

  • 36. The acute hemodynamic eeffects of alpha-methyldopa in man.
    WILSON WR; FISHER FD; KIRKENDALL WM
    J Chronic Dis; 1962 Sep; 15():907-13. PubMed ID: 14001103
    [No Abstract]   [Full Text] [Related]  

  • 37. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 38. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
    SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S
    N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424
    [No Abstract]   [Full Text] [Related]  

  • 40. [AGRANULOCYTOSIS AND MEDULLARY APLASIA DURING THERAPY WITH HYPOGLYCEMIC SULFONAMIDES. DEMONSTRATION OF AN ANTI-LEUKOCYTE ANTIBODY].
    TRAISSAC FJ; MOULINIER J; DANGOUMAU J; BERAUD C
    Presse Med (1893); 1965 Feb; 73():331-3. PubMed ID: 14238284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.